Modulation of glutamate receptors: Strategies for the development of novel antidepressants

Amino Acids

Volumn 23, Issue 1-3, 2002, Pages 153-159

  Skolnick, P ^a  

^a DOV Pharmaceutical Inc   (United States)

Author keywords

AMPA; AMPA receptor potentiators; Behavioral despair; Depression; NMDA antagonists

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; 2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 2,3 DIHYDRO 3,4 CYCLOPENTANO 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; 5,7 DICHLOROKYNURENIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARGININE; BIOGENIC AMINE; CITALOPRAM; DESIPRAMINE; DIZOCILPINE; DOPAMINE; ELIPRODIL; GLUTAMATE RECEPTOR; GLYCINE; IMIPRAMINE; KETAMINE; LY 392098; LY 451646; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; PARTIAL AGONIST; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; STRYCHNINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

COMPETITIVE INHIBITION; CONFERENCE PAPER; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG METABOLISM; DRUG UPTAKE; HUMAN; LIGAND BINDING; LONG TERM CARE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SYNAPSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HUMANS; MOTOR ACTIVITY; RECEPTORS, GLUTAMATE; SULFONAMIDES; SYNAPTIC TRANSMISSION; THIOPHENES;

STRYCHNOS TOXIFERA;

EID: 0036386829     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-001-0121-7     Document Type: Conference Paper

References (52)

1. Altar CA (1999) Neurotrophins and depression. TIPS 20: 59-61
2. Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C (1994) Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J Neurochem 63: 1021-1032
3. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair." Pharmacol Biochem & Behav 70: 187-192
4. Berman RM, Cappiello A, Anand A, Oren D, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychol 47: 351-354
5. Bettler B, Mulle C (1995) AMPA and kainate receptors. Neuropharmacol 34: 123-139
6. Borsini F, Meli A (1988) Is the forced swim test a suitable model for revealing antidepressant activity? Psychopharmacol 94: 147-160
7. Boyer PA, Skolnick P, Fossom LH (1998) Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. J Mol Neurosci 10: 219-233
8. Brandoli C, Sanna A, De Bernardi MA, Follesa P, Brooker G, Mocchetti I (1998) Brain-derived neurotrophic factor and basic fibroblast growth factor downregulate NMDA receptor function in cerebellar granule cells. J Neurosci 18: 7953-7961
9. Cameron HA, Tanapat P, Gould E (1998) Adrenal steroids and N-methyl-D-aspartate receptor activation regulate neurogenesis in the dentate gyrus of adult rats through a common pathway. Neurosci 82: 349-354
10. 3H]norepinephrine release from rat hippocampal slices. J Neurochem 63: 231-237
11. Duman RS, Heninger GR, Nestler EJ (1997a) A molecular and cellular theory of depression. Arch Gen Psychiat 54: 597-606
12. Duman RS, Nibuya M, Vaidya VA (1997b) A role for CREB in antidepressant action. In: Skolnick P (ed) Antidepressants: new pharmacological strategies. Humana Press, Totowa, pp 173-194
13. Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenyl-pyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci 91: 5104-5108
14. Gould E, Tanapat P (1999) Stress and hippocampal neurogenesis. Biol Psychiat 46: 1472-1479
15. Hall J, Thomas KL, Everitt BJ (2000) Rapid and selective induction of BDNF expression in the hippocampus during contextual learning. Nature Neurosci 3: 533-535
16. Harkin AJ, Bruce KH, Craft B, Paul IA (1999) Nitric oxide synthase inhibitors have antidepressant-like properties in mice 1. Acute treatments are active in the forced swim test. Eur J Pharmacol 372: 207-212
17. Harvey SC, Skolnick P (1999) Polyamine-like actions of aminoglycosides at recombinant N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 291: 285-291
18. Jordan S, Kramer GL, Zukas PK, Moeller M, Petty F (1994) In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine. Synapse 18: 294-297
19. Laurie DJ, Seeburg, PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur J Pharmacol 268: 335-345
20. Lauterborn JC, Rivera S, Stinis CT, Hayes VY, Isackson PJ, Gall CM (1996) Differential effects of protein synthesis inhibition on the activity-dependent expression of BDNF transcripts: evidence for immediate-early gene responses from specific promoters. J Neurosci 16: 7428-7436
21. Legutko B, Li X, Skolnick P (2001) Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacol 40: 1019-1027
22. Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P (2001) Antidepressant-like actions of an AMPA receptor potentiator (LY32098). Neuropharmacol 40: 1028-1033
23. Lipton SA, Rosenberg PA (1994) Excitatory amino acids as afinal common pathway for neurologic disorders. NEJM 330: 613-622
24. Lockhart B, Iop F, Closier M, Lestage P (2000) (S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide: (S18968-1) a positive modulator of AMPA receptor enhances (S)-AMPA-mediated [3H]noradrenaline release from rat hippocampal and frontal cortex slices. Eur J Pharmacol 401: 145-153
25. Lyons WE, Mamounas LA, Ricaurte GA, Coppola A, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96: 15239-15244
26. Maione S, Biggs CS, Rossi F, Fowler LJ, Whitton PS (1995) alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors modulate dopamine release in rat hippocampus and striatum. Neurosci Letts 193: 181-184
27. Malberg JE, Eisch AJ, Nestler AJ, Duman RS (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20: 9104-9110
28. Malenka RC, Nicoll RA (1999) Long-term potentiation - a decade of progress? Science 285: 1870-1874
29. Mamounas LA, Blue ME, Sluciak JA, Altar CA (1995) BDNF promotes the survival and sprouting of serotonergic axons in the rat brain. J Neurosci 15: 1729-1739
30. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20: 771-782
31. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA following chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15: 7539-7547
32. Nitta A, Ohmiya M, Sumetani A, Itoh M, Nomoto H, Furukawa Y, Furukawa S (1999) Brain-derived neurotrophic factor prevents neuronal cell death induced by corticosterone. J Neurosci Res 57: 227-235
33. Nowak G, Li Y, Paul IA (1996) Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment. Eur J Pharmacol 295: 75-85
34. Nowak G, Trullas R, Layer RT, Skolnick P, Paul IA (1993) Adaptive changes in the N-methyl-D-aspartate receptor complex after chronic treatment with imipramine and 1-aminocyclopropanecarboxylic acid. J Pharmacol Exp Ther 265: 1380-1386
35. Ornstein PL, Zimmerman DM, Arnold MB, Bleisch TJ, Cantrell B, Simon R, Zarrinmayeh H, Baker SR, Gates M, Tizzano JP, Schoepp DD, Bleakman D, Mendylzys A, Jarvie K, Hoo K, Deverill M, Kamboj R (2000) Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid (AMPA) receptors. J Med Chem 43: 4354-4358
36. Paul IA, Layer RT, Skolnick P, Nowak G (1993) Adaption of the N-methyl-D-aspartate receptor complex in rat front cortex following chronic treatment with electroconvulsive shock or imipramine. Eur J Pharmacol 247: 305-312
37. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P (1994) Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 269: 95-102
38. Petrie R, Reid IC, Stewart CA (2000) The N-methyl-D-aspartate receptor, synaptic plasticity, and depressed disorder. A critical review. Pharmacol & Ther 87: 11-25
39. Popik P, Wrobel M, Nowak G (2000) Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacol 39: 2278-2287
40. Porsolt RD, Lenegre A (1992) Behavioural models of depression. In: Elliott JM, Heal DJ, Marsden CA (eds) Experimental approaches to anxiety and depression. John Wiley and Sons, London, pp 73-85
41. Porsolt RD, Bertin A, Jalfre M (1977a) Behavioral despair in mice: a primary screening test for antidepressants. Arch Internat Pharmacodyn Ther 229: 327-336
42. Porsolt RD, Le Pichon M, Jalfre M (1977b) Depression: a new model sensitive to antidepressant treatments. Nature 266: 730-732
43. Russo-Neustadt A, Beard RC, Cotman CW (1999) Exercise, antidepressant medications, and enhanced brain derived neurophic factor expression. Neuropsychopharm 21: 679-682
44. Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor. Pharmacol Biochem Behav 56: 131-137
45. Skolnick P (1999) Antidepressants for the new millennium. Eur J Pharmacol 375: 31-41
46. Skolnick P, Legutko B, Li X, Bymaster FP (2001) Current perspectives on the development of non-biogenic amine based antidepressants. Pharmacol Res 43: 411-423
47. Steru L, Chermat R, Theirry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol 85: 367-370
48. Tao R, Ma Z, Auerbach SB (1997) Influence of AMPA/kainate receptors on extracellular 5-hydroxytryptamine in rat midbrain raphe and forebrain. Br J Pharmacol 121: 1707-1715
49. Trullas R (1997) Functional NMDA antagonists: a new class of antidepressant agents. In: Skolnick P (ed) Antidepressants: new pharmacological strategies. Humana Press, Totowa, pp 103-124
50. Vandergriff J, Huff K, Bond A, Lodge D (2001) Potentiation of responses to AMPA on central neurons by LY392098 and LY404187 in vivo. Neuropharm 40: 1003-1009
51. Wafford KA, Bain CJ, Le Bourdelles B, Whiting PJ, Kemp JA (1993) Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. NeuroReport 4: 1347-1349
52. Zafra F, Hengerer B, Leibrock J, Thoenen H, Lindholm D (1990) Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutamate receptors. J Neurosci 9: 3545-3550